On Monday Vistagen Therapeutics Inc (NASDAQ: VTGN) opened higher 7.61% from the last session, before settling in for the closing price of $3.94. Price fluctuations for VTGN have ranged from $1.90 to $4.52 over the past 52 weeks.
Healthcare Sector giant saw their annual sales surged by 35.63% over the last five years. Company’s average yearly earnings per share was noted 2.93% at the time writing. With a float of $27.73 million, this company’s outstanding shares have now reached $29.28 million.
Vistagen Therapeutics Inc (VTGN) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Vistagen Therapeutics Inc is 9.63%, while institutional ownership is 55.60%.
Vistagen Therapeutics Inc (VTGN) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.42 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.38) by -0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.32 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 2.93% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 17.83% during the next five years compared to 35.63% growth over the previous five years of trading.
Vistagen Therapeutics Inc (NASDAQ: VTGN) Trading Performance Indicators
Check out the current performance indicators for Vistagen Therapeutics Inc (VTGN). In the past quarter, the stock posted a quick ratio of 5.98. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 185.83.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.58, a number that is poised to hit -0.48 in the next quarter and is forecasted to reach -1.66 in one year’s time.
Technical Analysis of Vistagen Therapeutics Inc (VTGN)
Analysing the last 5-days average volume posted by the [Vistagen Therapeutics Inc, VTGN], we can find that recorded value of 0.54 million was better than the volume posted last year of 0.32 million. As of the previous 9 days, the stock’s Stochastic %D was 31.79%.
During the past 100 days, Vistagen Therapeutics Inc’s (VTGN) raw stochastic average was set at 84.87%, which indicates a significant increase from 57.29% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.31 in the past 14 days, which was higher than the 0.23 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.66, while its 200-day Moving Average is $2.84. Now, the first resistance to watch is $4.55. This is followed by the second major resistance level at $4.86. The third major resistance level sits at $5.07. If the price goes on to break the first support level at $4.03, it is likely to go to the next support level at $3.82. Should the price break the second support level, the third support level stands at $3.51.
Vistagen Therapeutics Inc (NASDAQ: VTGN) Key Stats
There are currently 30,680K shares outstanding in the company with a market cap of 130.08 million. Presently, the company’s annual sales total 490 K according to its annual income of -51,420 K. Last quarter, the company’s sales amounted to 240 K and its income totaled -15,100 K.
